ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GSK Gsk Plc

1,775.00
-8.50 (-0.48%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -8.50 -0.48% 1,775.00 1,771.00 1,771.50 1,779.00 1,764.50 1,773.50 9,685,415 16:35:19
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.80 72.91B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,783.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,820.00p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £72.91 billion. Gsk has a price to earnings ratio (PE ratio) of 14.80.

Gsk Share Discussion Threads

Showing 30151 to 30169 of 33175 messages
Chat Pages: Latest  1207  1206  1205  1204  1203  1202  1201  1200  1199  1198  1197  1196  Older
DateSubjectAuthorDiscuss
05/7/2022
09:49
It seems to be either sell for around £18 pre split or hold mid term ( end of year and first quarter next year ) and watching haleon stock rise and then sell
alibizzle
04/7/2022
16:13
Thanks Keyno
jonjoneil
04/7/2022
15:58
G'day,

Sold today @1797.

Got a wee bit nervous, re: split.

Will be interesting to watch.

cheers

dudishes
04/7/2022
15:56
"I was so undecided I just tossed a coin."

I admire your honesty, jonj. What a refreshing change from all the bs one reads on these boards. I hope it works out for you.

keyno
04/7/2022
15:51
Pleased to see that Interactive Investor are now paying interest on cash balances over £10k. I sold all my GSK holding (12.5K) this morning. I intend to buy them back after the split. I was so undecided I just tossed a coin.
jonjoneil
04/7/2022
15:48
I've sold out after owning for a few years.

Proceeds have gone into SUPR, big quarterly dividend payer.

igoe104
04/7/2022
14:32
According to the "sum of the parts" the two businesses are expected to trade at a premium to their combined values. Whether the separate listings will unlock this value in the short time remains to be seen. Personally, I shall miss the dividends and I'm not keen on owning a consumer health company in isolation.
tradermichael
04/7/2022
14:19
What benefit do current share holders get by holding? Shares in haleon which has a low divi and 10bln in debt?Does not sound like a bargain
mj19
04/7/2022
11:33
...sold at 18 and will see what happens after the split,i was there for income and it will be lower if i stay as it is..

I'm also only here for the income but in this case, despite the 35% drop in initial divis I'm staying with both new shares to see how things develop over time and because demergers usually work out well if you are patient. It's a risk as I could sell GSK and reinvest in a new high yielder, thus boosting my port income, but I believe I'll be better off the end by sticking with it.

Another point is that I still want a pharma in my port for diversification reasons and if I sold old GSK, I can't see any alternatives to new GSK which provide a reasonable yield. Similarly I wouldn't have Haleon if I sell now but I find it desirable as it increases my diversity even more as a consumer health product manufacturer. So both the new shares are welcome in my income port for this reason.

Very wide diversity is an essential feature of my income approach and it sometimes requires a little yield sacrifice

anhar
04/7/2022
11:09
Lippy - just done the same - for the same reason.
norry2
04/7/2022
10:49
agree with jonjoneil

sold at 18 and will see what happens after the split,i was there for income and it will be lower if i stay as it is..

lippy4
04/7/2022
09:12
What's the stamp duty to pay please?

As TM replied, it's 0.5% and is paid as part of the purchase cost when you bought the shares.

anhar
04/7/2022
09:07
Like Pfizer and GSK, I don't want to keep them in my portfolio. Just my view. I know no more than you.
jonjoneil
04/7/2022
08:59
That way I don't have to deal with Haleon

What's your reason for not wanting to deal with Haleon?

anhar
04/7/2022
06:27
What's the stamp duty to pay please ? I sold around £40k from my equiti ISA for GSK then used the money ( still in ISA as cash now not shares ) to buy another 50k of GSK which is in ISA again as shares . Am I liable ? This was in march. Thinking of selling if reaches £19 pre split and withdrawing from ISA which I know is cgt free
alibizzle
03/7/2022
14:24
I am quite relaxed about holding on but not sure the best way forward. I am thinking of placing a sell order for £18 next week, and if it triggers I will hope to buy back my full complement of New GSK. That way I don't have to deal with Haleon.
Not worried about CGT as all held in ISA, but will have to pay stamp duty on buy back.
Of course if GSK open at a premium, I will have missed out. C'est la vie.

jonjoneil
03/7/2022
13:57
Quite agree with those comments and I'm also retaining both as standalone investments. There's little mileage in getting too deeply tangled up in technical matters. The combined value is as priced now. Once separated it isn't likely to be wildly different.
patientcapital
03/7/2022
13:48
I think the Haleon divi increases will be held back for some time while they concentrate on reducing debt. Especially with rising interest rates.
jonjoneil
03/7/2022
12:53
Here's the bit that concerns me: 14 July, scrip dividend, whereby GSK investors get HAL shares (1 for 1). But, they are only releasing 80% of GSK's 68% holding in Consumer Health.

At the moment, I am unwilling to keep invested in a pig in a poke (something offered in such a way as to obscure its real nature or worth).

I don't get that reluctance TM. The value of Haleon (or any share) depends upon the market's perception of a host of factors such as assets, P/E, the quality of the business, yield, possible bid potential etc. There's nothing hidden, any more than with any company. I don't see why then it's a "pig in a poke". The temporary retained shareholdings of GSK, or Pfizer come to that, don't make any difference to the company itself. Both have stated they intend to dispose of their holdings after the lock up period.

As I've said despite the large divi cut from the two new shares over old GSK, I'm definitely going to retain my Haleon to see how it develops, especially its divis.

anhar
Chat Pages: Latest  1207  1206  1205  1204  1203  1202  1201  1200  1199  1198  1197  1196  Older